Press Room
Recent Press Releases
-
January 22, 2019
Gilead Sciences to Release Fourth Quarter and Full Year 2018 Financial Results on Monday, February 4, 2019 -
January 08, 2019
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) -
January 08, 2019
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) -
January 06, 2019
Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis -
January 06, 2019
Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
Media Inquiries
For additional information about our work, please contact the Gilead public affairs team by calling 1-800-GILEAD-5
Company Statements
Find important Gilead announcements, leadership perspectives, and other corporate communications.